Sarcopenia and excess visceral fat accumulation negatively affect early urinary function after I‐125 low‐dose‐rate brachytherapy for localized prostate cancer-Reference-Cited by-同舟云学术

Sarcopenia and excess visceral fat accumulation negatively affect early urinary function after I‐125 low‐dose‐rate brachytherapy for localized prostate cancer

Published:2022-12-15 Issue:4 Volume:30 Page:347-355
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Ogasawara Naoyuki¹²^ORCID,Nakiri Makoto¹^ORCID,Kurose Hirofumi¹,Ueda Kosuke¹,Chikui Katsuaki¹,Nishihara Kiyoaki¹,Matsuo Mitsunori¹,Suekane Shigetaka¹,Morimatsu Yoshitaka²,Murotani Kenta³,Muraki Koichiro⁴,Hattori Chikayuki⁴,Ogo Etsuyo⁴,Ishitake Tatsuya²,Igawa Tsukasa¹

Affiliation:

1. Department of Urology Kurume University School of Medicine Kurume Japan

2. Department of Environmental Medicine Kurume University School of Medicine Kurume Japan

3. Biostatistics Center Kurume University School of Medicine Kurume Japan

4. Department of Radiology Kurume University School of Medicine Kurume Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.15120

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement

3. Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy

4. Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric Goals

5. Sarcopenia: revised European consensus on definition and diagnosis